MiNK Therapeutics, Inc.INKTNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank82
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P82
Within normal range
vs 2Y Ago
2.2x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q3 202538.68%
Q2 2025-51.43%
Q1 2025-7.69%
Q4 2024-35.42%
Q3 202434.25%
Q2 202433.64%
Q1 202430.38%
Q4 2023-6.76%
Q3 202317.78%
Q2 2023-103.76%
Q1 20232277.27%
Q4 2022-57.14%
Q3 2022-7.69%
Q2 202245.83%
Q1 2022-33.33%
Q4 202158.14%
Q3 2021-95.45%
Q2 2021-57.14%
Q1 2021-158.78%
Q4 202074.24%
Q3 2020-16.67%
Q2 20200.00%
Q1 20200.00%